Stay updated on Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Sign up to get notified when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Version bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.
    Difference
    4%
    Check dated 2025-10-06T04:22:01.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the previous version tag v3.0.2. Overall, a reorganization/relabeling rather than adding new core content.
    Difference
    0.5%
    Check dated 2025-09-28T23:46:17.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:56:49.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T07:14:09.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location in Sterzing, Italy, along with new content related to drug safety and post-COVID conditions, while removing previous location details and references to COVID-19.
    Difference
    3%
    Check dated 2025-08-31T00:47:57.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T18:57:52.000Z thumbnail image

Stay in the know with updates to Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.